Title: Amarin, Omega-3, hypertriglyceridemia, cardiovascular, AMR101, ultra pure EPA, lipid science - Amarin
Description: Amarin is a clinical stage biopharmaceutical company with a lead program in Phase 3 for hypertriglyceridemia.
Keywords:Amarin, cardiovascular, Omega-3, hypertriglyceridemia, dyslipidemia, lipid science, research, development, drugs, central nervous system, Miraxion, Declan Doogan, Stuart Sedlack, Paresh Sonin, Jonathan Rowe AMR101, myasthenia gravis, EN101, triglyceride lowering, lipid, EPA, eicosapentaenoic acid, ethyl-EPA
